Number needed to treat with ursodeoxycholic acid therapy to prevent liver transplantation or death in primary biliary cholangitis

OBJECTIVE: The clinical benefit of ursodeoxycholic acid (UDCA) in primary biliary cholangitis (PBC) has never been reported in absolute measures. The aim of this study was to assess the number needed to treat (NNT) with UDCA to prevent liver transplantation (LT) or death among patients with PBC. MET...

पूर्ण विवरण

में बचाया:
ग्रंथसूची विवरण
में प्रकाशित:Gut
मुख्य लेखकों: Harms, Maren H, de Veer, Rozanne C, Lammers, Willem J, Corpechot, Christophe, Thorburn, Douglas, Janssen, Harry L A, Lindor, Keith D, Trivedi, Palak J, Hirschfield, Gideon M, Pares, Albert, Floreani, Annarosa, Mayo, Marlyn J, Invernizzi, Pietro, Battezzati, Pier Maria, Nevens, Frederik, Ponsioen, Cyriel Y, Mason, Andrew L, Kowdley, Kris V, Hansen, Bettina E, van Buuren, Henk R, van der Meer, Adriaan J
स्वरूप: Artigo
भाषा:Inglês
प्रकाशित: BMJ Publishing Group 2020
विषय:
Hepatology
ऑनलाइन पहुंच:https://ncbi.nlm.nih.gov/pmc/articles/PMC7398464/
https://ncbi.nlm.nih.gov/pubmed/31843787
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1136/gutjnl-2019-319057
टैग : टैग जोड़ें
कोई टैग नहीं, इस रिकॉर्ड को टैग करने वाले पहले व्यक्ति बनें!

समान संसाधन